BackGroup home
Taichu Biotechnology
Innovative Drug Non Clinical Research and Service Platform (CRO)
AceMab
AceMouse ™- The most perfect antibody fully humanized mouse platform (CRO)
Tarlead
Antibody drug process development and production service platform (CDMO)
TJR BIO
End-to-end Service from Oligonucleotide R&D to drug product manufacturing (CDMO)
Taichu (Shenzhen)
Consulting Services&Business Activities
Tarlead Biologics
Biologics  Development and Manufacturing（CDMO）
The company is anchored by a core team averaging over 10 years of industry tenure, bolstered by prior experience at globally recognized pharmaceutical enterprises.
Tarlead Biologics, a Taichu Group (CRDMO) subsidiary, delivers end-to-end CDMO services for antibody therapies  and ADCs/AOCs from its facility located in Suzhou, China. Leveraging a proprietary CHO platform with GS knockout, multi-copy gene integration, and defucosylation technologies, the company achieves high titers (>5 g/L) while maintaining >95% monomeric purity. Its N-1 perfusion and MES/QMS-enabled operations ensure cGMP-compliant production of 120+ annual batches, supporting global INDs with expertise in bispecific antibody scale-up.
Contact
Business Scope
Complete CMC development and application services from cell line construction to drug production. include:
Factory facilities
Facility Area:
8000 ㎡
Functional Zones:​
Production Area:
Drug Substance Manufacturing Suite, Drug Product Manufacturing Suite, Utilities System, GMP Warehouse, QC Laboratory
R&D Area:
Cell Line Screening, Upstream & Downstream Process Development, Analytical Method Development, Pilot Plant • Pilot Plant
Office Area:
Training Room, Archives Room, Conference Rooms, Offices
Technical Features​
Quality System

Tarlead Biologics has established a drug production quality management system that meets regulatory requirements such as FDA, EU, NMPA, WHO, etc. The quality system is continuously updated through quality management reviews and continuous improvement procedures. Quality risk management and knowledge management are integrated throughout the entire process of establishing and operating the quality system. Currently, it has successfully supported the application of seven IND projects in China, the United States, and Australia.

The specific quality management system is divided into six major systems, classified as follows:
  • 01
    Quality System
  • 02
    Matrials System
  • 03
    Production System
  • 04
    Packaging and Labeling
  • 05
    Laboratory System
  • 06
    Equipment and Facilities
Production Capacity
We operate a cGMP-compliant workshop featuring approximately 1,600 square meters of clean area, which includes three dedicated workshops for cell culture, purification, and formulation.
Cell Culture Workshop​​: Equipped with multi-scale disposable bioreactors (200L*1, 500L*1, 1000L*2), this facility supports an annual production capacity of approximately 40 batches.
Purification Workshop​​: Fitted with imported chromatography systems, columns, virus removal, and ultrafiltration equipment, it efficiently handles purification processes across scales from 200L to 1000L.
Formulation Workshop​​: Includes a fully automated washing, drying, filling, and capping integrated line capable of producing water-based injection products in various specifications (2ml–20ml). The line ensures 100% online weight verification and delivers an annual output of 400,000 bottles.
Backed by an experienced team averaging over 8 years of expertise from leading global pharmaceutical companies, we deliver end-to-end excellence in biopharmaceutical manufacturing.
Company Dynamics
More